HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, K. A. Articles by Rowen, M. Search for Related Content PubMed PubMed Citation Articles by Brown, K. A. Articles by Rowen, M.

Impact of Antianginal Medications, Peak Heart Rate and Stress Level on the Prognostic Value of a Normal Exercise Myocardial Perfusion Imaging Study

Cardiology Unit, Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont

Correspondence: For correspondence or reprints contact Kenneth & Brown, MD, Cardiology Unit, Medical Center Hospital of Vermont, Burlington, VT 05401.

ABSTRACT

We sought to determine whether antianginal medications or the level of achieved stress affect the prognostic value of a normal exercise ²⁰¹Tl study. We studied 261 patients with a normal exercise ²⁰¹Tl study for 23 ± 6 mo. Antianginal mediations were taken at the time of stress testing in 128 patients. Peak heart rate ranged from 82 to 217 bpm; percent maximal predicted heart rate ranged from 42% to 136%. Chi-square analysis was used to determine the relationship of cardiac events to antianginal medications and stress indices. Primary cardiac events were defined as cardiac death or nonfatal myocardial infarction. Primary cardiac events occurred in six patients yielding an annual incidence of 1.2% per year. There was no significant relationship between cardiac event rate and antianginal medication use or any stress index, including Bruce stage, peak heart rate or blood pressure or percent maximal predicted heart rate achieved. The risk of cardiac death or nonfatal myocardial infarction inpatients with a normal exercise ²⁰¹Tl is low and is not affected by concurrent antianginal treatment or degree of stress achieved.

This article has been cited by other articles:

				L. D. Metz, M. Beattie, R. Hom, R. F. Redberg, D. Grady, and K. E. Fleischmann The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography: A Meta-Analysis J. Am. Coll. Cardiol., January 16, 2007; 49(2): 227 - 237. [Abstract] [Full Text] [PDF]

				J. Candell-Riera, O. Pereztol-Valdés, C. Santana-Boado, M. Missorici, G. Oller-Martínez, S. Aguadé-Bruix, J. Castell-Conesa, M. Simó, M. J. Díez-Castro, and J. Soler-Soler Relationship Between the Location of the Most Severe Myocardial Perfusion Defects, the Most Severe Coronary Artery Stenosis, and the Site of Subsequent Myocardial Infarction J. Nucl. Med., April 1, 2001; 42(4): 558 - 563. [Abstract] [Full Text]

				P. Y. Marie, N. Danchin, F. Branly, M. Angioi, A. Grentzinger, J. M. Virion, B. Brouant, P. Olivier, G. Karcher, Y. Juilliere, et al. Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: Evidence of a protective effect of beta-blocking antianginal medications J. Am. Coll. Cardiol., July 1, 1999; 34(1): 113 - 121. [Abstract] [Full Text] [PDF]